Department for Molecular Biomedical Research, Unit for Medical Biotechnology, VIB, Technologiepark 927, 9052, Ghent, Belgium.
Microb Cell Fact. 2013 Dec 9;12:122. doi: 10.1186/1475-2859-12-122.
Membrane protein research is frequently hampered by the low natural abundance of these proteins in cells and typically relies on recombinant gene expression. Different expression systems, like mammalian cells, insect cells, bacteria and yeast are being used, but very few research efforts have been directed towards specific host cell customization for enhanced expression of membrane proteins. Here we show that by increasing the intracellular membrane production by interfering with a key enzymatic step of lipid synthesis, enhanced expression of membrane proteins in yeast is achieved.
We engineered the oleotrophic yeast, Yarrowia lipolytica, by deleting the phosphatidic acid phosphatase, PAH1, which led to massive proliferation of endoplasmic reticulum (ER) membranes. For all eight tested representatives of different integral membrane protein families, we obtained enhanced protein accumulation levels and in some cases enhanced proteolytic integrity in the ∆pah1 strain. We analysed the adenosine A2AR G-protein coupled receptor case in more detail and found that concomitant induction of the unfolded protein response in the ∆pah1 strain enhanced the specific ligand binding activity of the receptor. These data indicate an improved quality control mechanism for membrane proteins accumulating in yeast cells with proliferated ER.
We conclude that redirecting the metabolic flux of fatty acids away from triacylglycerol- and sterylester-storage towards membrane phospholipid synthesis by PAH1 gene inactivation, provides a valuable approach to enhance eukaryotic membrane protein production. Complementary to this improvement in membrane protein quantity, UPR co-induction further enhances the quality of the membrane protein in terms of its proper folding and biological activity. Importantly, since these pathways are conserved in all eukaryotes, it will be of interest to investigate similar engineering approaches in other cell types of biotechnological interest, such as insect cells and mammalian cells.
膜蛋白的研究经常受到这些蛋白质在细胞中天然丰度低的限制,通常依赖于重组基因表达。不同的表达系统,如哺乳动物细胞、昆虫细胞、细菌和酵母,都被使用,但很少有研究致力于针对特定宿主细胞的定制化,以增强膜蛋白的表达。在这里,我们展示了通过干扰脂质合成的关键酶步骤来增加细胞内膜的产生,可以实现酵母中膜蛋白的增强表达。
我们通过敲除磷酸脂酸磷酸酶(PAH1)来工程改造产油酵母 Yarrowia lipolytica,这导致内质网(ER)膜的大量增殖。对于测试的八种不同整合膜蛋白家族的代表,我们都获得了增强的蛋白积累水平,在某些情况下,在 ∆pah1 菌株中还增强了蛋白的水解完整性。我们更详细地分析了腺苷 A2AR G 蛋白偶联受体的情况,发现 ∆pah1 菌株中未折叠蛋白反应的伴随诱导增强了受体的特定配体结合活性。这些数据表明,在增殖的 ER 中积累的膜蛋白中,改善了质量控制机制。
我们得出结论,通过 PAH1 基因失活将脂肪酸的代谢通量从三酰基甘油和甾醇酯储存转移到膜磷脂合成,可以提供一种增强真核膜蛋白生产的有价值的方法。除了这种膜蛋白数量的改善外,UPR 共诱导进一步增强了膜蛋白的质量,使其正确折叠和具有生物活性。重要的是,由于这些途径在所有真核生物中都保守,因此研究其他具有生物技术意义的细胞类型(如昆虫细胞和哺乳动物细胞)中的类似工程化方法将是很有意义的。